BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28801348)

  • 1. Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignancies.
    Yannakou CK; Jones K; Ryland GL; Thompson ER; Reid G; McBean M; Trainer A; Westerman D; Blombery P
    J Clin Pathol; 2018 Jan; 71(1):84-87. PubMed ID: 28801348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
    Andrés-Zayas C; Suárez-González J; Rodríguez-Macías G; Dorado N; Osorio S; Font P; Carbonell D; Chicano M; Muñiz P; Bastos M; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
    Mol Oncol; 2021 Sep; 15(9):2273-2284. PubMed ID: 33533142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Primary Cancers With Hematologic Malignancies and Germline Predisposition: A Case Series.
    Yun J; Lee DS; Lee S; Yun H
    Ann Lab Med; 2024 Sep; 44(5):446-449. PubMed ID: 38449380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline Genetic Predisposition to Hematologic Malignancy.
    Furutani E; Shimamura A
    J Clin Oncol; 2017 Mar; 35(9):1018-1028. PubMed ID: 28297620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications.
    Godley LA; DiNardo CD; Bolton K
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432218. PubMed ID: 38768412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing.
    Ptashkin RN; Ewalt MD; Jayakumaran G; Kiecka I; Bowman AS; Yao J; Casanova J; Lin YD; Petrova-Drus K; Mohanty AS; Bacares R; Benhamida J; Rana S; Razumova A; Vanderbilt C; Balakrishnan Rema A; Rijo I; Son-Garcia J; de Bruijn I; Zhu M; Lachhander S; Wang W; Haque MS; Seshan VE; Wang J; Liu Y; Nafa K; Borsu L; Zhang Y; Aypar U; Suehnholz SP; Chakravarty D; Park JH; Abdel-Wahab O; Mato AR; Xiao W; Roshal M; Yabe M; Batlevi CL; Giralt S; Salles G; Rampal R; Tallman M; Stein EM; Younes A; Levine RL; Perales MA; van den Brink MRM; Dogan A; Ladanyi M; Berger MF; Brannon AR; Benayed R; Zehir A; Arcila ME
    Nat Commun; 2023 Oct; 14(1):6895. PubMed ID: 37898613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of tumour-in-normal contamination assessment from whole genome sequencing.
    Mitchell J; Milite S; Bartram J; Walker S; Volkova N; Yavorska O; Zarowiecki M; Chalker J; Thomas R; Vago L; Sosinsky A; Caravagna G
    Nat Commun; 2024 Jan; 15(1):323. PubMed ID: 38238294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications.
    Laguna JC; Pastor B; Nalda I; Hijazo-Pechero S; Teixido C; Potrony M; Puig-Butillé JA; Mezquita L
    Br J Cancer; 2024 May; 130(9):1420-1431. PubMed ID: 38532104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.
    Raymond VM; Gray SW; Roychowdhury S; Joffe S; Chinnaiyan AM; Parsons DW; Plon SE;
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26590952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine Learning Predictability of Clinical Next Generation Sequencing for Hematologic Malignancies to Guide High-Value Precision Medicine.
    Kim GYE; Noshad M; Stehr H; Rojansky R; Gratzinger D; Oak J; Brar R; Iberri D; Kong C; Zehnder J; Chen JH
    AMIA Annu Symp Proc; 2021; 2021():641-650. PubMed ID: 35308914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of blood malignancies among Iranian population: an overview.
    Ghayour-Mobarhan M; Zangouei AS; Hosseinirad SM; Mojarrad M; Moghbeli M
    Diagn Pathol; 2020 May; 15(1):44. PubMed ID: 32375828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic testing for germline predisposition to hematologic malignancies.
    Hwang SM
    Blood Res; 2024 Mar; 59(1):12. PubMed ID: 38485837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings.
    Ceyhan-Birsoy O; Fiala E; Rana S; Sheehan M; Kennedy J; Yelskaya Z; Rai V; Li Y; Yang C; Wong D; Rijo I; Casanova J; Somar J; Mehta N; Park H; Ostafi S; Arora K; Padunan A; Ewalt MD; Aypar U; Terraf P; Misyura M; Haque S; Behr GG; Haque T; Sulis M; Geyer MB; Forlenza C; Thompson MC; Carlo M; Latham A; Liu Y; Zehir A; Brannon R; Berger M; Diaz LA; Dogan A; Ladanyi M; Petrova-Drus K; Nafa K; Offit K; Arcila M; Stadler ZK; Walsh MF; Mandelker D
    Haematologica; 2024 Apr; ():. PubMed ID: 38572560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene mutational pattern and expression level in 560 acute myeloid leukemia patients and their clinical relevance.
    Zhu YM; Wang PP; Huang JY; Chen YS; Chen B; Dai YJ; Yan H; Hu Y; Cheng WY; Ma TT; Chen SJ; Shen Y
    J Transl Med; 2017 Aug; 15(1):178. PubMed ID: 28830460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes.
    Nazha A; Al-Issa K; Hamilton BK; Radivoyevitch T; Gerds AT; Mukherjee S; Adema V; Zarzour A; Abuhadra N; Patel BJ; Hirsch CM; Advani A; Przychodzen B; Carraway HE; Maciejewski JP; Sekeres MA
    Leukemia; 2017 Dec; 31(12):2848-2850. PubMed ID: 28819282
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication.
    Pelttari LM; Shimelis H; Toiminen H; Kvist A; Törngren T; Borg Å; Blomqvist C; Bützow R; Couch F; Aittomäki K; Nevanlinna H
    Clin Genet; 2018 Mar; 93(3):595-602. PubMed ID: 28802053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline and somatic drivers in inherited hematologic malignancies.
    Zoller J; Trajanova D; Feurstein S
    Front Oncol; 2023; 13():1205855. PubMed ID: 37904876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of Myelodysplastic Syndromes.
    Saygin C; Godley LA
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent somatic mutations and low germline predisposition mutations in Korean ALL patients.
    Shin SY; Lee H; Lee ST; Choi JR; Jung CW; Koo HH; Kim SH
    Sci Rep; 2021 Apr; 11(1):8893. PubMed ID: 33903686
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.